Literature DB >> 8097470

Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines.

C R Maliszewski1, K Grabstein, W C Fanslow, R Armitage, M K Spriggs, T A Sato.   

Abstract

The ligand for the B cell surface antigen CD40 was recently cloned from a murine thymoma cDNA library and shown to be expressed on activated T cells. In this study, we investigate the biological effects of murine recombinant CD40 ligand. The recombinant CD40 ligand expressed on the CV-1/EBNA monkey fibroblast cell line directly activated resting B cell to express elevated levels of cell surface class II major histocompatibility complex and CD23 molecules. CD40 ligand also stimulated B cell proliferation, reaching maximal levels on day 2 of culture and declining thereafter. This effect was positively regulated by other cytokines, most notably interleukin (IL)-4 and IL-5. By itself, CD40 ligand had no effect upon immunoglobulin secretion by B cells. However, when B cells were treated with CD40 ligand plus cytokines, immunoglobulin secretion was stimulated in a cytokine-dependent and isotype-specific manner. IL-4 was a potent co-stimulator of IgE and IgG1 in the presence of CD40 ligand, and IL-5 acted synergistically with IL-4 in these responses as well as in IgM and IgG3 production. Taken together, the results indicate that CD40 ligand is a potent regulatory molecule for B cell growth and differentiation, and its activities are potentiated in a cytokine-specific manner.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097470     DOI: 10.1002/eji.1830230510

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

1.  Short-circuiting long-lived humoral immunity by the heightened engagement of CD40.

Authors:  Loren D Erickson; Brigit G Durell; Laura A Vogel; Brian P O'Connor; Marilia Cascalho; Teruhito Yasui; Hitoshi Kikutani; Randolph J Noelle
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Expression of L-selectin (CD62L) discriminates Th1- and Th2-like cytokine-producing memory CD4+ T cells.

Authors:  H Kanegane; Y Kasahara; Y Niida; A Yachie; S Sughii; K Takatsu; N Taniguchi; T Miyawaki
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  Characterization of a phenotypically unique population of CD13+ dendritic cells resident in the spleen.

Authors:  Yan Zhuang; Waithaka Mwangi; Wendy C Brown; William C Davis; Jayne C Hope; Guy H Palmer
Journal:  Clin Vaccine Immunol       Date:  2006-09

4.  Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease.

Authors:  Kristen R Crook; Mengyao Jin; Michael F Weeks; Rishi R Rampersad; Robert M Baldi; Amy S Glekas; Yajuan Shen; Denise A Esserman; Paul Little; Todd A Schwartz; Peng Liu
Journal:  J Leukoc Biol       Date:  2015-01-12       Impact factor: 4.962

5.  Murine B1 B cells require IL-5 for optimal T cell-dependent activation.

Authors:  L D Erickson; T M Foy; T J Waldschmidt
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

6.  Humoral immune responses in CD40 ligand-deficient mice.

Authors:  B R Renshaw; W C Fanslow; R J Armitage; K A Campbell; D Liggitt; B Wright; B L Davison; C R Maliszewski
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

7.  Loss of CD154 impairs the Th2 extrafollicular plasma cell response but not early T cell proliferation and interleukin-4 induction.

Authors:  Adam F Cunningham; Karine Serre; Elodie Mohr; Mahmood Khan; Kai-Michael Toellner
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

8.  Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.

Authors:  B Samal; Y Sun; G Stearns; C Xie; S Suggs; I McNiece
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

9.  Diminished expression of CD40 ligand by activated neonatal T cells.

Authors:  S Nonoyama; L A Penix; C P Edwards; D B Lewis; S Ito; A Aruffo; C B Wilson; H D Ochs
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

10.  The in vitro derivation of phenotypically mature and diverse B cells from immature spleen and bone marrow precursors.

Authors:  Kirstin M Roundy; Amanda C Jacobson; Janis J Weis; John H Weis
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.